Keywords: جفیتینیب، ایرسا; EGFR tyrosine kinase inhibitor; Gefitinib; Osimertinib; Afatinib;
مقالات ISI جفیتینیب، ایرسا (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: جفیتینیب، ایرسا; Carcinoma; Chemotherapy; Erlotinib; Gefitinib; Targeted therapy;
Keywords: جفیتینیب، ایرسا; Drug co-delivery; Polymer nanoparticles; Spheroids; Lung cancer; Gefitinib; Vorinostat;
Keywords: جفیتینیب، ایرسا; Gefitinib; Intervertebral disc degeneration; EGFR; Thermosensitive injectable hydrogel;
Keywords: جفیتینیب، ایرسا; Gefitinib; Erlotinib; Resveratrol; Chalcones; Quinazolines; Cytotoxicity;
Keywords: جفیتینیب، ایرسا; Quinazolines; Alkylation; Hydrazinolysis; HeLa; MDA-MB231; Gefitinib; Cytotoxicity;
Keywords: جفیتینیب، ایرسا; Afatinib; Erlotinib; Gefitinib; Mutation; NSCLC;
Keywords: جفیتینیب، ایرسا; Non-small cell lung cancer; Epidermal growth factor receptor (EGFR); Tyrosine kinase inhibitors (TKI); TKI resistance; Osimertinib; Gefitinib; Erlotinib; Afatinib;
Keywords: جفیتینیب، ایرسا; Gefitinib; Collagen scaffold; Meniscus; EGFR;
Keywords: جفیتینیب، ایرسا; Acquired resistance; EGFR mutation; Gefitinib; Autopsy; Molecular target therapy; T790M mutation;
Keywords: جفیتینیب، ایرسا; Lung cancer; Adenocarcinoma; Gefitinib; Liver metastasis; Epidermal growth factor receptor tyrosine kinase inhibitor;
Keywords: جفیتینیب، ایرسا; Epidermal growth factor receptor; Tyrosine kinase inhibitors; EGFR-TKI; Gefitinib; Erlotinib; Lung cancer; Pregnancy; Pharmacology
Keywords: جفیتینیب، ایرسا; drug resistance; gefitinib; non-small-cell lung cancer; proteomics; secretomics
Keywords: جفیتینیب، ایرسا; cost-utility analysis; EGFR; first-line; gefitinib; Thailand;
Keywords: جفیتینیب، ایرسا; Acquired resistance; Gefitinib; EGFR-tyrosine kinase inhibitor; Non-small cell lung cancer; Post-progression survival (PPS); Failure togefitinib;
Keywords: جفیتینیب، ایرسا; Afatinib; Chemotherapy; Dacomitinib; Epidermal growth factor receptor; Erlotinib; Gefitinib; Non-small cell lung cancer; Pharmacokinetics; Tyrosine kinase inhibitors;
Keywords: جفیتینیب، ایرسا; Meta-analysis; Lung cancer; Gefitinib; Afatinib; Erlotinib; Ethnicity; Trial design;
Keywords: جفیتینیب، ایرسا; Non-squamous non-small cell lung cancer; Pemetrexed; Gefitinib; Cisplatin; East Asian patients
Keywords: جفیتینیب، ایرسا; Lung cancer cells; Gold nanoparticle conjugates; Gefitinib; Cell viability; Surface-enhanced Raman scattering;
Keywords: جفیتینیب، ایرسا; Gefitinib; Endometrial cancer; Epidermal growth factor receptor (EGFR); Soluble EGFR; Estrogen receptor; Progesterone receptor;
Gefitinib and Methotrexate to Treat Ectopic Pregnancies with a Pre-Treatment Serum hCG 1000-10,000â¯IU/L: Phase II Open Label, Single Arm Multi-Centre Trial
Keywords: جفیتینیب، ایرسا; Gefitinib; Methotrexate; Ectopic pregnancy; Medical treatment; Phase II;
Phase I and II trial on infusional 5-fluorouracil and gefitinib in combination with preoperative radiotherapy in rectal cancer: 10-years median follow-up
Keywords: جفیتینیب، ایرسا; Rectal cancer; Gefitinib; Log term follow-up; Chemoradiotherapy;
Fabrication and characterization of gefitinib-releasing polyurethane foam as a coating for drug-eluting stent in the treatment of bronchotracheal cancer
Keywords: جفیتینیب، ایرسا; Gefitinib; Polyurethane (PU) foams; Drug-eluting stent; Polymeric microspheres; Bronchotracheal cancer; Controlled release;
Gefitinib for Epidermal Growth Factor Receptor Activated Osteoarthritis Subpopulation Treatment
Keywords: جفیتینیب، ایرسا; Osteoarthritis; Disease subpopulation; Epidermal growth factor receptor; Gefitinib;
Continuation of gefitinib beyond progression in patients with EGFR mutation-positive non-small-cell lung cancer: A phase II single-arm trial
Keywords: جفیتینیب، ایرسا; Gefitinib; Non-small cell lung cancer; EGFR mutation;
Investigation of inclusion behaviour of gefitinib with epichlorohydrin-β-cyclodextrin polymer: preparation of binary complex, stoichiometric determination and characterization
Keywords: جفیتینیب، ایرسا; API; active pharmaceutical ingredient; ATP; adenosine tri phosphate; BCS; biopharmaceutical classification system; DSC; differential scanning calorimetry; DTA; differential thermal analysis; EGFR; epidermal growth factor receptor; Epi-β-CD; polymerized e
Shikonin enhances sensitization of gefitinib against wild-type EGFR non-small cell lung cancer via inhibition PKM2/stat3/cyclinD1 signal pathway
Keywords: جفیتینیب، ایرسا; Shikonin; Gefitinib; PKM2; STAT3; CyclinD1;
Phase II trial of gefitinib plus pemetrexed after relapse using first-line gefitinib in patients with non-small cell lung cancer harboring EGFR gene mutations
Keywords: جفیتینیب، ایرسا; NSCLC; Non-small cell lung cancer; EGFR; Epidermal growth factor receptor; OS; Overall survival; PD; Progressive disease; PFS; Progression-free survival; Gefitinib; Pemetrexed; EGFR mutation; Beyond progressive disease;
Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study
Keywords: جفیتینیب، ایرسا; Erlotinib; Gefitinib; G719X; Heterogeneity outcome; L861Q;
An Evolving Algorithm to Select and Sequence Therapies in EGFR Mutation-positive NSCLC: A Strategic Approach
Keywords: جفیتینیب، ایرسا; Afatinib; Del19; Gefitinib; L858R; T790M;
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non-Small-cell Lung Cancer Patients
Keywords: جفیتینیب، ایرسا; Afatinib; Depth of response; EGFR mutation-positive NSCLC; Gefitinib;
Systematic bioinformatic approaches reveal novel gene expression signatures associated with acquired resistance to EGFR targeted therapy in lung cancer
Keywords: جفیتینیب، ایرسا; DEGs; Differentially Expressed Genes; ES; effect size; EGFR; epidermal Growth Factor Receptor; FDR; False Discovery Rate; GEO; Gene Expression Omnibus; GSEA; Gene Set Enrichment Analysis; IMEx; International Molecular Exchange; MSigDB; Molecular Signature
Endocannabinoid Signaling in Embryonic Neuronal Motility and Cell-Cell Contact - Role of mGluR5 and TRPC3 Channels
Keywords: جفیتینیب، ایرسا; 2-AG; 2-arachidonoyl glycerol; [Ca2+]i; intracellular free calcium concentration; Afatinib; N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide; AM251; 1-(2,4-dichlorophenyl)-5-(4-iodophe
Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials
Keywords: جفیتینیب، ایرسا; EGFR blocker; Elderly; Gefitinib; NSCLC; Tyrosine kinase inhibitor;
Metronomic vinorelbine is directly active on Non Small Cell Lung Cancer cells and sensitizes the EGFRL858R/T790M cells to reversible EGFR tyrosine kinase inhibitors
Keywords: جفیتینیب، ایرسا; ABCG2; ATP-binding cassette sub-family G member 2; CI; combination index; D-VNR; deacetyl-vinorelbine; EGFR; epidermal growth factor receptor; FBS; fetal bovine serum; IC50; inhibitory concentration 50; mVNR; metronomic vinorelbine; NSCLC; Non Small Cell
EGFR tyrosine kinase inhibition decreases cardiac remodeling and SERCA2a/NCX1 depletion in streptozotocin induced cardiomyopathy in C57/BL6 mice
Keywords: جفیتینیب، ایرسا; EGFR; DbCM; Gefitinib; C57/BL6; SERCA;
Gefitinib enhances radiotherapeutic effects of 131I-hEGF targeted to EGFR by increasing tumor uptake of hEGF in tumor xenografts
Keywords: جفیتینیب، ایرسا; Gefitinib; hEGF; 131I; EGFR; Radiotherapy;
Curcumin co-treatment ameliorates resistance to gefitinib in drug-resistant NCI-H1975 lung cancer cells
Keywords: جفیتینیب، ایرسا; Lung neoplasms; Cell line, tumor; Curcumin; Cell proliferation; Apoptosis; Receptor, epidermal growth factor; Gefitinib;
The APPLE Trial: Feasibility and Activity of AZD9291 (Osimertinib) Treatment on Positive PLasma T790M in EGFR-mutant NSCLC Patients. EORTC 1613
Keywords: جفیتینیب، ایرسا; AZD9291; Blood; EGFR mutation; Gefitinib; Lung;
A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancer
Keywords: جفیتینیب، ایرسا; Uncommon EGFR mutation; Epidemiology; Erlotinib; Exon 20 insertion; Gefitinib; T790Â M mutation;
Design of gefitinib-loaded poly (l-lactic acid) microspheres via a supercritical anti-solvent process for dry powder inhalation
Keywords: جفیتینیب، ایرسا; Gefitinib; Supercritical anti-solvent process; Dry powder inhaler; Lactose; Two-stage impinger;
Original ResearchApatinib enhances antitumour activity of EGFR-TKIs in non-small cell lung cancer with EGFR-TKI resistance
Keywords: جفیتینیب، ایرسا; NSCLC; Apatinib; Gefitinib; EGFR; VEGFR;
Tailoring the particle microstructures of gefitinib by supercritical CO2 anti-solvent process
Keywords: جفیتینیب، ایرسا; Supercritical CO2; Gefitinib; Microstructure; Polymorph; Micronization;
Combination Osimertinib and Gefitinib in C797S and T790M EGFR-Mutated Non-Small Cell Lung Cancer
Keywords: جفیتینیب، ایرسا; Osimertinib; Gefitinib; C797S mutation; EGFR mutation; Non-small cell lung cancer;
Heterogeneity in Immune Marker Expression after Acquisition of Resistance to EGFR Kinase Inhibitors: Analysis of a Case with Small Cell Lung Cancer Transformation
Keywords: جفیتینیب، ایرسا; PD-L1; EGFR mutation; Acquired resistance; Gefitinib; Autopsy; Immune biomarkers;
Therapeutic Efficacy Comparison of 5 Major EGFR-TKIs in Advanced EGFR-positive Non-Small-cell Lung Cancer: A Network Meta-analysis Based on Head-to-Head Trials
Keywords: جفیتینیب، ایرسا; Afatinib; Dacomitinib; Erlotinib; Gefitinib; Icotinib;
Gefitinib and pyrrolidine dithiocarbamate decrease viral replication and cytokine production in dengue virus infected human monocyte cultures
Keywords: جفیتینیب، ایرسا; Dengue virus; Gefitinib; Cytokines; EGFR; NOD receptor;
Effects of Histamine 2-receptor Antagonists and Proton Pump Inhibitors on the Pharmacokinetics of Gefitinib in Patients With Non-small-cell Lung Cancer
Keywords: جفیتینیب، ایرسا; CYP2C19; Drug interaction; Gefitinib; Histamine 2-receptor antagonists; Proton pump inhibitors;
Induction of CYP1A1 increases gefitinib-induced oxidative stress and apoptosis in A549 cells
Keywords: جفیتینیب، ایرسا; A549 cells; CYP1A1; Gefitinib; Oxidative stress; Apoptosis;
Enigmas in tumor resistance to kinase inhibitors and calculation of the drug resistance index for cancer (DRIC)
Keywords: جفیتینیب، ایرسا; Acalabrutinib; Alectinib; Brigatinib; Ceritinib; Crizotinib; Dabrafenib; Dasatinib; Erlotinib; Gefitinib; Ibrutinib; Imatinib; Lorlatinib; Nilotinib; Osimertinib; Rociletinib; Trametinib; Vemurafenib;